interesting photophysical properties.1b,c,2 Moreover, we
have finally developed a programmable synthesis of
tetraarylethenes through a Pd-catalyzed sequential tet-
raarylation of a vinyl 2-pyrimidyl sulfide platform.3 As
for our application to the synthesis of pharmaceutically
important molecules, we established a programmable
synthesis of tamoxifen-type tetrasubstituted olefins using
alkynyl(2-pyridyl)silane as a platform.4
Rapid Synthesis of CDP840 with
2-Pyrimidyl Vinyl Sulfide as a Platform
Nobuhiro Muraoka, Masahiro Mineno,
Kenichiro Itami,*,† and Jun-ichi Yoshida*
Department of Synthetic Chemistry and Biological
Chemistry, Graduate School of Engineering, Kyoto
University, Nishikyo-ku, Kyoto 615-8510, Japan
During these investigations toward multisubstituted
olefins, we became aware that such olefins should also
be excellent precursors for multisubstituted ethane struc-
tures by functionalizing the remaining CdC core of
multisubstituted olefins (Scheme 1). As functionalizing
methods, for example, carbometalation (X ) C, Y ) M),
hydrometalation (H, M), hydrogenation (H, H), and
epoxidation (-O-) may be applicable. In this paper, we
report on a rapid synthesis of CDP840 (1) using 2-py-
rimidyl vinyl sulfide as a platform.
itami@chem.nagoya-u.ac.jp; yoshida@sbchem.kyoto-u.ac.jp
Received May 24, 2005
CDP840 (1), which has an interesting 1,1,2-triaryle-
thane structure, is a potential therapeutic agent for
asthma as a selective phosphodiesterase (PDE) IV inhibi-
tor.5 PDE IV is believed to be the dominant isozyme
present in inflammatory cells and airway smooth muscle.
Inhibition of PDE IV leads to an increase in the concen-
tration of cyclic GMP, and gives rise to suppression of
cellular function in inflammatory cells.
A rapid synthesis of CDP840 (a potential therapeutic agent
for asthma), using 2-pyrimidyl vinyl sulfide as a platform,
has been established. This method includes a stereoselective
double Mizoroki-Heck-type arylation, a Liebeskind-Srogl-
type cross-coupling reaction, and a Pd/C-catalyzed hydro-
genation.
The synthesis of densely substituted (functionalized)
organic structures has been an important subject in
organic synthesis. In view of their synthesis as well as
potential applications as functional materials and phar-
maceuticals, we have been investigating the chemistry
(synthesis and properties) of multisubstituted olefins
during the last several years. In particular, we have
developed a number of syntheses of multisubstituted
olefins based on a sequential installation of substituents
on a CdC or CtC core of an appropriate starting
material (platform).1-4
For example, we have developed a programmable
synthesis of triarylethenes through a Pd-catalyzed se-
quential triarylation using vinyl(2-pyridyl)silane or vi-
nylboronate as a platform.1,2 From the triarylethene-
based extended π-system library, we were able to find a
number of interesting fluorescent materials as well as
Several syntheses of CDP840 including both racemic
and asymmetric approaches were reported so far.6,7
However, they suffered from a relatively long procedure
(6-7 steps). We envisaged that the sequence of double
Mizoroki-Heck-type arylation and cross-coupling start-
ing from 2-pyrimidyl vinyl sulfide (2)3,8 followed by
hydrogenation of the CdC bond would afford CDP840 (1)
very rapidly (Scheme 2). Such a synthesis would offer
an opportunity for diversity-oriented synthesis, which
would enable the production and screening of a series of
CDP840-type triarylethanes.
(5) Celltech Therapeutics LTD, U.S. Patent No. 5,608, 070.
(6) Previous syntheses: (a) Celltech Therapeutics LTD, U.S. Patent
No. 5,622,977. (b) Houpis, I. N.; Molina, A.; Dorziotis, I.; Reamer, R.
A.; Volante, R. P.; Reider, P. J. Tetrahedron Lett. 1997, 38, 7131. (c)
Lynch, J. E.; Choi, W.-B.; Churchill, H. R. O.; Volante, R. P.; Reamer,
R. A.; Ball, R. G. J. Org. Chem. 1997, 62, 9223. (d) Alexander, R. P.;
Warrellow, G. J.; Eaton, M. A. W.; Boyd, E. C.; Head, J. C.; Porter, J.
R.; Brown, J. A.; Reuberson, J. T.; Hutchinson, B.; Turner, P.; Boyce,
B.; Barnes, D.; Mason, B.; Cannell, A.; Taylor, R. J.; Zomaya, A.;
Millican, A.; Leonard, J.; Morphy, R.; Wales, M.; Perry, M.; Allen, R.
A.; Gozzard, N.; Hughes, B.; Higgs, G. Bioorg. Med. Chem. 2002, 12,
1451. (e) Aggarwal, V, K.; Bae, I.; Lee, H.-Y.; Richardson, J.; Williams,
D. T. Angew. Chem., Int. Ed. 2003, 42, 3274.
† Present address: Research Center for Materials Science, Nagoya
University, Nagoya 464-8602, Japan.
(1) Vinyl(2-pyridyl)silane as a platform: (a) Itami, K.; Nokami, T.;
Ishimura, Y.; Mitsudo, K.; Kamei, T.; Yoshida, J. J. Am. Chem. Soc.
2001, 123, 11577. (b) Itami, K.; Ushiogi, Y.; Nokami, T.; Ohashi, Y.;
Yoshida, J. Org. Lett. 2004, 6, 3695. (c) Itami, K.; Ohashi, Y.; Yoshida,
J. J. Org. Chem. 2005, 70, 2778. Also see: (d) Itami, K.; Mitsudo, K.;
Kamei, T.; Koike, T.; Nokami, T.; Yoshida, J. J. Am. Chem. Soc. 2000,
122, 12013. (e) Itami, K.; Nokami, T.; Yoshida, J. J. Am. Chem. Soc.
2001, 123, 5600.
(2) Vinyl boronate pinacol ester as a platform: Itami, K.; Tonogaki,
K.; Ohashi, Y.; Yoshida, J. Org. Lett. 2004, 6, 4093.
(7) The configuration of the enantiomer that shows the activity is
R.6
(3) Vinyl 2-pyrimidyl sulfide as a platform: Itami, K.; Mineno, M.;
Muraoka, N.; Yoshida, J. J. Am. Chem. Soc. 2004, 126, 11778.
(4) Alkynyl(2-pyridyl)silane as a platform: (a) Itami, K.; Kamei, T.;
Yoshida, J. J. Am. Chem. Soc. 2003, 125, 14670. (b) Kamei, T.; Itami,
K.; Yoshida, J. Adv. Synth. Catal. 2004, 346, 1824.
(8) Vinyl sulfide 2 was easily prepared from 2-thiocyanatopyrimidine
(derived from 2-mercaptopyrimidine) and vinylmagnesium bromide:
(a) Miyashita, A.; Nagasaki, I.; Kawano, A.; Suzuki, Y.; Iwamoto, K.;
Higashino, T. Heterocycles 1997, 45, 745. (b) Nagasaki, I.; Matsumoto,
M.; Yamashita, M.; Miyashita, A. Heterocycles 1999, 51, 1015.
10.1021/jo0510437 CCC: $30.25 © 2005 American Chemical Society
Published on Web 07/22/2005
J. Org. Chem. 2005, 70, 6933-6936
6933